Author Question: Is the 821 billion that the government would spend on incentive programs and compensation for higher ... (Read 74 times)

Engineer

  • Hero Member
  • *****
  • Posts: 527
Is the 821 billion that the government would spend on incentive programs and compensation for higher energy prices part of the opportunity cost of producing electricity?
 
  What will be an ideal response?

Question 2

When an investor buys a corporate bond, the face value of the bond is
 
  A) a dividend payment on the bond. B) a loan to the corporation.
  C) a measure of ownership in the corporation. D) the coupon rate of the bond.



joshraies

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

The incentive programs change what electricity providers buy in order to produce electricity with lower emissions. The goods and services forgone are the opportunity cost of these programs. Compensation for higher energy prices is a transfer payment from taxpayers to consumers. Nothing is forgone and so it is not an opportunity cost.

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library